| Previous close | 3.7000 |
| Open | 3.5200 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 3.4620 - 3.5200 |
| 52-week range | 3.4620 - 3.5200 |
| Volume | 1,800 |
| Avg. volume | N/A |
| Market cap | 250.948M |
| Beta (5Y monthly) | 1.52 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5260 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP) Revenues
Celebrations may be in order for MEI Pharma, Inc. ( NASDAQ:MEIP ) shareholders, with the analysts delivering a...
- Simply Wall St.
What Type Of Shareholders Own The Most Number of MEI Pharma, Inc. (NASDAQ:MEIP) Shares?
If you want to know who really controls MEI Pharma, Inc. ( NASDAQ:MEIP ), then you'll have to look at the makeup of its...
- Business Wire
MEI PHARMA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of MEI Pharma, Inc. - MEIP
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into MEI Pharma, Inc. (NasdaqGS: MEIP).
© 2021 Verizon Media. All rights reserved.
